|
Name |
Methyl (9Z,15Z)-9,15-octadecadienoate
|
Molecular Formula | C19H34O2 | |
IUPAC Name* |
methyl (9Z,15Z)-octadeca-9,15-dienoate
|
|
SMILES |
CC/C=C\CCCC/C=C\CCCCCCCC(=O)OC
|
|
InChI |
InChI=1S/C19H34O2/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19(20)21-2/h4-5,10-11H,3,6-9,12-18H2,1-2H3/b5-4-,11-10-
|
|
InChIKey |
OTROKOXHZSGHEN-NKIGAPEHSA-N
|
|
Synonyms |
cis,cis-9,15-Linoleic acid; Methyl cis-9,cis-15-linoleate; Methyl (9Z,15Z)-9,15-octadecadienoate; 17309-05-6; Methyl cis,cis-9,15-octadecadienoate; 9YU6AH66NX; Methyl 9,15-linoleate, (9Z,15Z)-; 9,15-Octadecadienoic acid, methyl ester, (9Z,15Z)-; methyl (9Z,15Z)-octadeca-9,15-dienoate; (9Z,15Z)-9,15-Octadecadienoic acid methyl ester; UNII-9YU6AH66NX; DTXSID501287830; (9Z,15Z)-methyl 9,15-linoleate; (Z,Z)-9,15-OCTADECADIENOIC ACID METHYL ESTER; Q27273385
|
|
CAS | 17309-05-6 | |
PubChem CID | 13639290 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 294.5 | ALogp: | 6.7 |
HBD: | 0 | HBA: | 2 |
Rotatable Bonds: | 15 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 26.3 | Aromatic Rings: | 0 |
Heavy Atoms: | 21 | QED Weighted: | 0.222 |
Caco-2 Permeability: | -4.88 | MDCK Permeability: | 0.00004430 |
Pgp-inhibitor: | 0.001 | Pgp-substrate: | 0 |
Human Intestinal Absorption (HIA): | 0.06 | 20% Bioavailability (F20%): | 0.998 |
30% Bioavailability (F30%): | 1 |
Blood-Brain-Barrier Penetration (BBB): | 0.769 | Plasma Protein Binding (PPB): | 97.99% |
Volume Distribution (VD): | 3.204 | Fu: | 1.60% |
CYP1A2-inhibitor: | 0.577 | CYP1A2-substrate: | 0.613 |
CYP2C19-inhibitor: | 0.445 | CYP2C19-substrate: | 0.207 |
CYP2C9-inhibitor: | 0.38 | CYP2C9-substrate: | 0.937 |
CYP2D6-inhibitor: | 0.592 | CYP2D6-substrate: | 0.883 |
CYP3A4-inhibitor: | 0.802 | CYP3A4-substrate: | 0.124 |
Clearance (CL): | 5.283 | Half-life (T1/2): | 0.909 |
hERG Blockers: | 0.176 | Human Hepatotoxicity (H-HT): | 0.089 |
Drug-inuced Liver Injury (DILI): | 0.024 | AMES Toxicity: | 0.037 |
Rat Oral Acute Toxicity: | 0.045 | Maximum Recommended Daily Dose: | 0.058 |
Skin Sensitization: | 0.961 | Carcinogencity: | 0.185 |
Eye Corrosion: | 0.275 | Eye Irritation: | 0.52 |
Respiratory Toxicity: | 0.816 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001605 | 0.791 | D0O1TC | 0.538 | ||||
ENC001660 | 0.791 | D0OR6A | 0.484 | ||||
ENC001645 | 0.762 | D0O1PH | 0.482 | ||||
ENC001435 | 0.754 | D0UE9X | 0.463 | ||||
ENC001711 | 0.726 | D0G2MW | 0.358 | ||||
ENC001714 | 0.726 | D09ANG | 0.354 | ||||
ENC001659 | 0.700 | D0Z5BC | 0.352 | ||||
ENC001688 | 0.690 | D0H2YX | 0.349 | ||||
ENC001680 | 0.690 | D09SRR | 0.324 | ||||
ENC001657 | 0.690 | D07ILQ | 0.319 |